{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:21:57Z","timestamp":1786980117922,"version":"build-2736575974"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004869","name":"Westf\u00e4lische Wilhelms-Universit\u00e4t M\u00fcnster","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004869","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The NCD cohort study RIFADE (RIsk FActors of DEmentia) investigates the interaction of risk factors and neurocognitive disorders (NCDs) due to Alzheimer\u2019s disease (NCD-AD) and NCD of vascular type (NCD-vascular). Retrospective recruitment referred to a period from 2007 to 2018 in a single centre. In addition to the baseline visit, follow-up visits took place at 3, 6, 12\u00a0months followed by yearly visits. Visit times varied in part depending on adherence. The study also comprises an EEG bank and a bank with cerebral MRI (c-MRI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Inclusion criteria were broad in order to cover a wide range of patterns of NCD. At baseline, patients underwent a large panel of assessments, e.g. including clinical history, diagnostic evaluation for NCD according to DSM-IV and NINDS AIREN criteria, a cognitive test battery including the DemTect, the clock drawing test and the Instrumental-Activities-of-Daily-Living-scale of Lawton and Brodie, EEG and c-MRI. At each follow-up visit, cognitive tests were repeated, in most cases also EEGs and in some cases c-MRIs. Numerous risk factors (RF) including vascular RF, atrial fibrillation, heart failure, sleep apnoea and lifestyle factors such as sedentary lifestyle, low cognitive style and smoking were evaluated for presence and for correction status at each visit, and modulation of uncorrected RF was initiated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Overall, 126 subjects with a clinical diagnosis of NCD were included (52% female, mean age 71\u2009\u00b1\u200910.6\u00a0years (range 35e86)), number of follow-up visits per subject 2.9\u2009\u00b1\u20092.4, observation time per subject 3.4\u2009\u00b1\u20092.8\u00a0years). Of these, 55\/28\/17% presented with the clinical stages subjective cognitive decline (SCD)\/mild cognitive impairment (MCI)\/dementia (major NCD). Clinical diagnoses, retrospectively re-evaluated according to DSM-5, were 5\/21\/68\/6% Alzheimer\u00b4s disease (NCD-AD)\/vascular NCD (NCD-vascular) \/ mixed NCD (NCD-AD\u2009+\u2009NCD-vascular)\/unspecified NCD. First longitudinal results revealed a mean DemTect score at baseline 12.6\u2009\u00b1\u20094.2 vs last visit 12.0\u2009\u00b1\u20094.8 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.08) and a clock drawing test score at baseline 1.9\u2009\u00b1\u20091.3 vs last visit 2.3\u2009\u00b1\u20091.5 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001). Of all subjects with MCI or major NCD (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200957), 19 improved in the clinical stage from baseline to last visit (33.3%). Sixteen subjects progressed from SCD or MCI (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009104) to major NCD (15.4%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The German NCD cohort RIFADE comprises patients with all clinical stages of NCD. A considerable subgroup improved in clinical stage. Further analysis is needed to answer the question of whether modulation of multiple risk factors provides a favourable effect on cognitive outcome in NCD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00406-022-01516-3","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T02:03:12Z","timestamp":1669168992000},"page":"941-952","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The neurocognitive disorder cohort RIFADE: Aims, methods, first results showing cognitive improvement in a subgroup"],"prefix":"10.1007","volume":"273","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7232-1960","authenticated-orcid":false,"given":"Bruno","family":"Baumann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Lipka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"J\u00e4nner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milenko","family":"Kujovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,21]]},"reference":[{"issue":"9503","key":"1516_CR1","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1016\/s0140-6736(05)67889-0","volume":"366","author":"CP Ferri","year":"2005","unstructured":"Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Scazufca M (2005) Global prevalence of dementia: a Delphi consensus study. The lancet 366(9503):2112\u20132117. https:\/\/doi.org\/10.1016\/s0140-6736(05)67889-0","journal-title":"The lancet"},{"key":"1516_CR2","unstructured":"World Health Organization (2021). Dementia. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia"},{"issue":"1","key":"1516_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12931-019-1217-5","volume":"20","author":"SM von Siemens","year":"2019","unstructured":"von Siemens SM, Perneczky R, Vogelmeier CF, Behr J, Kauffmann-Guerrero D, Alter P, Kahnert K (2019) The association of cognitive functioning as measured by the DemTect with functional and clinical characteristics of COPD: results from the COSYCONET cohort. Respir Res 20(1):1\u201313. https:\/\/doi.org\/10.1186\/s12931-019-1217-5","journal-title":"Respir Res"},{"issue":"3","key":"1516_CR4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1027\/1016-9040.11.3.161","volume":"11","author":"L B\u00e4ckman","year":"2006","unstructured":"B\u00e4ckman L, MacDonald SW (2006) Death and cognition: Viewing a 1962 concept through 2006 spectacles. Eur Psychol 11(3):161. https:\/\/doi.org\/10.1027\/1016-9040.11.3.161","journal-title":"Eur Psychol"},{"issue":"6","key":"1516_CR5","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nrneurol.2017.63","volume":"13","author":"YT Wu","year":"2017","unstructured":"Wu YT, Beiser AS, Breteler MM, Fratiglioni L, Helmer C, Hendrie HC, Brayne C (2017) The changing prevalence and incidence of dementia over time\u2014current evidence. Nat Rev Neurol 13(6):327\u2013339. https:\/\/doi.org\/10.1038\/nrneurol.2017.63","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"1516_CR6","doi-asserted-by":"publisher","first-page":"e519","DOI":"10.1212\/wnl.0000000000010022","volume":"95","author":"FJ Wolters","year":"2020","unstructured":"Wolters FJ, Chibnik LB, Waziry R, Anderson R, Berr C, Beiser A, Hofman A (2020) Twenty-seven-year time trends in dementia incidence in Europe and the United States: The Alzheimer Cohorts Consortium. Neurology 95(5):e519\u2013e531. https:\/\/doi.org\/10.1212\/wnl.0000000000010022","journal-title":"Neurology"},{"issue":"10248","key":"1516_CR7","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/s0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, Mukadam N (2020) Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet 396(10248):413\u2013446. https:\/\/doi.org\/10.1016\/s0140-6736(20)30367-6","journal-title":"The Lancet"},{"issue":"6","key":"1516_CR8","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1111\/joim.13227","volume":"289","author":"I Lisko","year":"2021","unstructured":"Lisko I, Kulmala J, Annetorp M, Ngandu T, Mangialasche F, Kivipelto M (2021) How can dementia and disability be prevented in older adults: where are we today and where are we going? J Intern Med 289(6):807\u2013830. https:\/\/doi.org\/10.1111\/joim.13227","journal-title":"J Intern Med"},{"issue":"3","key":"1516_CR9","doi-asserted-by":"publisher","first-page":"313","DOI":"10.14283\/jpad.2021.15","volume":"8","author":"XX Zhang","year":"2021","unstructured":"Zhang XX, Tian Y, Wang ZT, Ma YH, Tan L, Yu JT (2021) The epidemiology of Alzheimer\u2019s disease modifiable risk factors and prevention. J Prev Alzheimer Dis 8(3):313\u2013321. https:\/\/doi.org\/10.14283\/jpad.2021.15","journal-title":"J Prev Alzheimer Dis"},{"issue":"1","key":"1516_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1001\/jamaneurol.2021.4161","volume":"79","author":"S Salloway","year":"2022","unstructured":"Salloway S, Chalkias S, Barkhof F, Burkett P, Barakos J, Purcell D, Smirnakis K (2022) Amyloid-related imaging abnormalities in 2 phase 3 studies evaluating aducanumab in patients with early Alzheimer disease. JAMA Neurol 79(1):13\u201321. https:\/\/doi.org\/10.1001\/jamaneurol.2021.4161","journal-title":"JAMA Neurol"},{"issue":"2","key":"1516_CR11","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/gps.1042","volume":"19","author":"E Kalbe","year":"2004","unstructured":"Kalbe E, Kessler J, Calabrese P, Smith R, Passmore AP, Brand MA, Bullock R (2004) DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry 19(2):136\u2013143. https:\/\/doi.org\/10.1002\/gps.1042","journal-title":"Int J Geriatr Psychiatry"},{"key":"1516_CR12","doi-asserted-by":"publisher","first-page":"153331752094980","DOI":"10.1177\/1533317520949805","volume":"35","author":"GS Aycicek","year":"2020","unstructured":"Aycicek GS, \u00c7al\u0131skan H, Ozsurekci C, Unsal P, Kessler J, Kalbe E, Esme M, Dogrul RT, Balc\u0131 C, Seven U, Karabulut E, Halil M, Cankurtaran M, Yavuz BB (2020) A Reliable tool for assessing MCI and Dementia: Validation Study of DemTect for Turkish Population. Am J Alzheimers Dis Demen 35:1533317520949805. https:\/\/doi.org\/10.1177\/1533317520949805","journal-title":"Am J Alzheimers Dis Demen"},{"issue":"6","key":"1516_CR13","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/1099-1166(200006)15:6%3C548::aid-gps242%3E3.0.co;2-u","volume":"15","author":"KI Shulman","year":"2000","unstructured":"Shulman KI (2000) Clock-drawing: is it the ideal cognitive screening test? Int J Geriatr Psychiatry 15(6):548\u2013561. https:\/\/doi.org\/10.1002\/1099-1166(200006)15:6%3C548::aid-gps242%3E3.0.co;2-u","journal-title":"Int J Geriatr Psychiatry"},{"key":"1516_CR14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/geront\/9.3_part_1.179","volume":"9","author":"MP Lawton","year":"1969","unstructured":"Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9:179\u2013186. https:\/\/doi.org\/10.1093\/geront\/9.3_part_1.179","journal-title":"Gerontologist"},{"issue":"11","key":"1516_CR15","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/nrneurol.2014.181","volume":"10","author":"PS Sachdev","year":"2014","unstructured":"Sachdev PS, Blacker D, Blazer DG, Ganguli M, Jeste DV, Paulsen JS, Petersen RC (2014) Classifying neurocognitive disorders: the DSM-5 approach. Nat Rev Neurol 10(11):634\u2013642. https:\/\/doi.org\/10.1038\/nrneurol.2014.181","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"1516_CR16","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1212\/wnl.43.2.250","volume":"43","author":"GC Rom\u00e1n","year":"1993","unstructured":"Rom\u00e1n GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Scheinberg P (1993) Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology 43(2):250\u2013250. https:\/\/doi.org\/10.1212\/wnl.43.2.250","journal-title":"Neurology"},{"issue":"12","key":"1516_CR17","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","volume":"44","author":"JL Cummings","year":"1994","unstructured":"Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J (1994) The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 44(12):2308\u20132314. https:\/\/doi.org\/10.1212\/WNL.44.12.2308","journal-title":"Neurology"},{"key":"1516_CR18","unstructured":"Iber, Conrad & Ancoli-Israel, Sonia & Chesson, A.L. & Quan, Stuart. (2007). The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications. Westchester, IL: American Academy of Sleep Medicine."},{"issue":"6","key":"1516_CR19","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/gps.930080606","volume":"8","author":"KI Shulman","year":"1993","unstructured":"Shulman KI, Pushkar Gold D, Cohen CA, Zucchero CA (1993) Clock-drawing and dementia in the community: A longitudinal study. Int J Geriatr Psychiatry 8(6):487\u2013496. https:\/\/doi.org\/10.1002\/gps.930080606","journal-title":"Int J Geriatr Psychiatry"},{"issue":"8","key":"1516_CR20","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1001\/archneur.65.8.1091","volume":"65","author":"SE O'Bryant","year":"2008","unstructured":"O\u2019Bryant SE, Waring SC, Cullum CM, Hall J, Lacritz L, Massman PJ, Lupo PJ, Reisch JS, Doody R (2008) Staging dementia using clinical dementia rating scale sum of boxes scores: A Texas Alzheimer\u2019s research consortium study. Arch Neurol 65(8):1091\u20131095. https:\/\/doi.org\/10.1001\/archneur.65.8.1091","journal-title":"Arch Neurol"},{"issue":"5","key":"1516_CR21","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/0013-4694(91)90203-G","volume":"79","author":"MC Salinsky","year":"1991","unstructured":"Salinsky MC, Oken BS, Morehead L (1991) Test-retest reliability in EEG frequency analysis. Electroencephalogr Clin Neurophysiol 79(5):382\u2013392. https:\/\/doi.org\/10.1016\/0013-4694(91)90203-G","journal-title":"Electroencephalogr Clin Neurophysiol"},{"issue":"12","key":"1516_CR22","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/jhh.2010.54","volume":"24","author":"G Parati","year":"2010","unstructured":"Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, Kario K, Lurbe E, Manolis A, Mengden T, O\u2019Brien E, Ohkubo T, Padfield P, Palatini P, Pickering TG, Redon J, Revera M, Ruilope LM, Shennan A, Mancia G (2010) European Society of Hypertension practice guidelines for home blood pressure monitoring. J Human Hypertens 24(12):779\u2013785. https:\/\/doi.org\/10.1038\/jhh.2010.54","journal-title":"J Human Hypertens"},{"issue":"2","key":"1516_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/ajh.2010.194","volume":"24","author":"GS Stergiou","year":"2011","unstructured":"Stergiou GS, Bliziotis IA (2011) Home blood pressure monitoring in the diagnosis and treatment of hypertension: A systematic review. Am J Hypertens 24(2):123\u2013134. https:\/\/doi.org\/10.1038\/ajh.2010.194","journal-title":"Am J Hypertens"},{"key":"1516_CR24","unstructured":"Granacher, U., M\u00fchlbauer, T., Bridenbaugh, S., Wehrle, A., Kressig, R.W. (2010). Altersunterschiede beim Gehen unter Einfach- und Mehrfacht\u00e4tigkeit. Deutsche Zeitschrift f\u00fcr Sportmedizin"},{"key":"1516_CR25","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry J Mental Sci 134:382\u2013389. https:\/\/doi.org\/10.1192\/bjp.134.4.382","journal-title":"Br J Psychiatry J Mental Sci"},{"issue":"24","key":"1516_CR26","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1212\/wnl.0000000000004741","volume":"89","author":"ER McGrath","year":"2017","unstructured":"McGrath ER, Beiser AS, DeCarli C, Plourde KL, Vasan RS, Greenberg SM, Seshadri S (2017) Blood pressure from mid-to late life and risk of incident dementia. Neurology 89(24):2447\u20132454. https:\/\/doi.org\/10.1212\/wnl.0000000000004741","journal-title":"Neurology"},{"issue":"2","key":"1516_CR27","doi-asserted-by":"publisher","first-page":"300","DOI":"10.2337\/dc15-1588","volume":"39","author":"S Chatterjee","year":"2016","unstructured":"Chatterjee S, Peters SA, Woodward M, Mejia Arango S, Batty GD, Beckett N, Huxley RR (2016) Type 2 diabetes as a risk factor for dementia in women compared with men: a pooled analysis of 2.3 million people comprising more than 100,000 cases of dementia. Diabetes care 39(2):300\u2013307. https:\/\/doi.org\/10.2337\/dc15-1588","journal-title":"Diabetes care"},{"issue":"4","key":"1516_CR28","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3233\/JAD-141521","volume":"44","author":"A Ramirez","year":"2015","unstructured":"Ramirez A, Wolfsgruber S, Lange C, Kaduszkiewicz H, Weyerer S, Werle J, Pentzek M, Fuchs A, Riedel-Heller SG, Luck T, M\u00f6sch E, Bickel H, Wiese B, Prokein J, K\u00f6nig H-H, Brettschneider C, Breteler MM, Maier W, Jessen F, Scherer M (2015) Elevated HbA1c is associated with increased risk of incident dementia in primary care patients. J Alzheimer Dis JAD 44(4):1203\u20131212. https:\/\/doi.org\/10.3233\/JAD-141521","journal-title":"J Alzheimer Dis JAD"},{"issue":"2","key":"1516_CR29","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1001\/jamaoto.2017.2513","volume":"144","author":"DG Loughrey","year":"2018","unstructured":"Loughrey DG, Kelly ME, Kelley GA, Brennan S, Lawlor BA (2018) Association of age related hearing loss with cognitive function, cognitive impairment, and dementia: a systematic review and meta-analysis (vol 144, pg 115, 2018). JAMA Otolaryngol Head Neck Surg 144(2):176\u2013176. https:\/\/doi.org\/10.1001\/jamaoto.2017.2513","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"1","key":"1516_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.trci.2016.11.003","volume":"3","author":"H Hikichi","year":"2017","unstructured":"Hikichi H, Kondo K, Takeda T, Kawachi I (2017) Social interaction and cognitive decline: Results of a 7-year community intervention. Alzheimer Dement Transl Res Clin Interv 3(1):23\u201332. https:\/\/doi.org\/10.1016\/j.trci.2016.11.003","journal-title":"Alzheimer Dement Transl Res Clin Interv"},{"issue":"2","key":"1516_CR31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/brainsci7020022","volume":"7","author":"PJ Gallaway","year":"2017","unstructured":"Gallaway PJ, Miyake H, Buchowski MS, Shimada M, Yoshitake Y, Kim AS, Hongu N (2017) Physical activity: a viable way to reduce the risks of mild cognitive impairment, Alzheimer\u2019s disease, and vascular dementia in older adults. Brain Sci 7(2):22. https:\/\/doi.org\/10.3390\/brainsci7020022","journal-title":"Brain Sci"},{"issue":"10","key":"1516_CR32","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1002\/gps.5582","volume":"36","author":"M Zuin","year":"2021","unstructured":"Zuin M, Roncon L, Passaro A, Bosi C, Cervellati C, Zuliani G (2021) Risk of dementia in patients with atrial fibrillation Short versus long follow-up A systematic review an d meta-analysis. Int J Geriatr Psychiatr 36(10):1488\u20131500. https:\/\/doi.org\/10.1002\/gps.5582","journal-title":"Int J Geriatr Psychiatr"},{"issue":"1","key":"1516_CR33","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2174\/1567205012666141218144035","volume":"12","author":"H Chen","year":"2015","unstructured":"Chen H, Liu S, Ji L, Wu T, Ma F, Ji Y, Huang G (2015) Associations between Alzheimer\u2019s disease and blood homocysteine, vitamin B12, and folate: a case-control study. Curr Alzheimer Res 12(1):88\u201394. https:\/\/doi.org\/10.2174\/1567205012666141218144035","journal-title":"Curr Alzheimer Res"},{"issue":"7","key":"1516_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11910-021-01123-0","volume":"21","author":"G Seda","year":"2021","unstructured":"Seda G, Matwiyoff G, Parrish JS (2021) Effects of Obstructive Sleep Apnea and CPAP on Cognitive Function. Curr Neurol Neurosci Rep 21(7):1\u20136. https:\/\/doi.org\/10.1007\/s11910-021-01123-0","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1516_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/adr-210004","volume":"5","author":"M Fernandes","year":"2021","unstructured":"Fernandes M, Placidi F, Mercuri NB, Liguori C (2021) The importance of diagnosing and the clinical potential of treating obstructive sleep apnea to delay mild cognitive impairment and Alzheimer\u2019s disease: a special focus on cognitive performance. J Alzheimer Dis Rep 5:1\u201319. https:\/\/doi.org\/10.3233\/adr-210004","journal-title":"J Alzheimer Dis Rep"},{"issue":"5","key":"1516_CR36","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1513\/annalsats.202004-313oc","volume":"18","author":"AE Beaudin","year":"2021","unstructured":"Beaudin AE, Raneri JK, Ayas NT, Skomro RP, Fox N, Hirsch Allen AM, Hanly PJ (2021) Cognitive function in a sleep clinic cohort of patients with obstructive sleep apnea. Ann Am Thorac Soc 18(5):865\u2013875. https:\/\/doi.org\/10.1513\/annalsats.202004-313oc","journal-title":"Ann Am Thorac Soc"},{"key":"1516_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsab076","author":"GL Dunietz","year":"2021","unstructured":"Dunietz GL, Chervin RD, Burke JF, Conceicao AS, Braley TJ (2021) Obstructive sleep apnea treatment and dementia risk in older adults. Sleep. https:\/\/doi.org\/10.1093\/sleep\/zsab076","journal-title":"Sleep"},{"key":"1516_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105054","volume":"145","author":"AE Mullins","year":"2020","unstructured":"Mullins AE, Kam K, Parekh A, Bubu OM, Osorio RS, Varga AW (2020) Obstructive sleep apnea and its treatment in aging: effects on Alzheimer\u2019s disease biomarkers, cognition, brain structure and neurophysiology. Neurobiol Dis 145:105054. https:\/\/doi.org\/10.1016\/j.nbd.2020.105054","journal-title":"Neurobiol Dis"},{"key":"1516_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2019.101250","volume":"50","author":"OM Bubu","year":"2020","unstructured":"Bubu OM, Andrade AG, Umasabor-Bubu OQ, Hogan MM, Turner AD, de Leon MJ, Osorio RS (2020) Obstructive sleep apnea, cognition and Alzheimer\u2019s disease: a systematic review integrating three decades of multidisciplinary research. Sleep Med Rev 50:101250. https:\/\/doi.org\/10.1016\/j.smrv.2019.101250","journal-title":"Sleep Med Rev"},{"key":"1516_CR40","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000018492","author":"J Li","year":"2020","unstructured":"Li J, Wu Y, Zhang D, Nie J (2020) Associations between heart failure and risk of dementia: A PRISMA-compliant meta-analysis. Medicine. https:\/\/doi.org\/10.1097\/md.0000000000018492","journal-title":"Medicine"},{"issue":"4","key":"1516_CR41","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/joim.12287","volume":"277","author":"P Cermakova","year":"2015","unstructured":"Cermakova P, Eriksdotter M, Lund LH, Winblad B, Religa P, Religa D (2015) Heart failure and Alzheimer\u2032 s disease. J Intern Med 277(4):406\u2013425. https:\/\/doi.org\/10.1111\/joim.12287","journal-title":"J Intern Med"},{"key":"1516_CR42","doi-asserted-by":"publisher","unstructured":"Supprian,\u00a0T., Kessler,\u00a0H., Retz,\u00a0W., R\u00f6sler,\u00a0M., Grunwald,\u00a0I., Reith,\u00a0W., & Falkai,\u00a0P. (2003). Marklagerver\u00e4nderungen bei neurodegenerativen und vaskul\u00e4ren Demenzerkrankungen. https:\/\/doi.org\/10.22028\/D291-20725","DOI":"10.22028\/D291-20725"},{"key":"1516_CR43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neubiorev.2020.11.007","volume":"120","author":"H-Y Hu","year":"2021","unstructured":"Hu H-Y, Ou Y-N, Shen X-N, Qu Y, Ma Y-H, Wang Z-T, Dong Q, Tan L, Yu J-T (2021) White matter hyperintensities and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 36 prospective studies. Neurosci Biobehav Rev 120:16\u201327. https:\/\/doi.org\/10.1016\/j.neubiorev.2020.11.007","journal-title":"Neurosci Biobehav Rev"},{"issue":"8","key":"1516_CR44","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","volume":"12","author":"JM Wardlaw","year":"2013","unstructured":"Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O\u2019Brien JT, Barkhof F, Benavente OR, Black SE, Brayne C, Breteler M, Chabriat H, DeCarli C, de Leeuw F-E, Doubal F, Duering M, Fox NC, Dichgans M (2013) Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 12(8):822\u2013838. https:\/\/doi.org\/10.1016\/S1474-4422(13)70124-8","journal-title":"Lancet Neurol"},{"issue":"11","key":"1516_CR45","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.jalz.2018.01.007","volume":"14","author":"FJ Wolters","year":"2018","unstructured":"Wolters FJ, Segufa RA, Darweesh SK, Bos D, Ikram MA, Sabayan B, Sedaghat S (2018) Coronary heart disease, heart failure, and the risk of dementia: a systematic review and meta-analysis. Alzheimers Dement 14(11):1493\u20131504. https:\/\/doi.org\/10.1016\/j.jalz.2018.01.007","journal-title":"Alzheimers Dement"},{"key":"1516_CR46","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2617970","author":"G Tini","year":"2020","unstructured":"Tini G, Scagliola R, Monacelli F, La Malfa G, Porto I, Brunelli C, Rosa GM (2020) Alzheimer\u2019s disease and cardiovascular disease: a particular association. Cardiol Res Pract. https:\/\/doi.org\/10.1155\/2020\/2617970","journal-title":"Cardiol Res Pract"},{"key":"1516_CR47","doi-asserted-by":"publisher","unstructured":"Gaillard, F., Secara, R. Medial temporal lobe atrophy score. Reference article, Radiopaedia.org. (accessed on 07 Apr 2022) https:\/\/doi.org\/10.53347\/rID-28451","DOI":"10.53347\/rID-28451"},{"issue":"5","key":"1516_CR48","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","volume":"87","author":"CR Jack","year":"2016","unstructured":"Jack CR, Bennett DA, Blennow K, Carrillo MC, Feldman HH, Frisoni GB, Hampel H, Jagust WJ, Johnson KA, Knopman DS, Petersen RC, Scheltens P, Sperling RA, Dubois B (2016) A\/t\/n: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology 87(5):539\u2013547. https:\/\/doi.org\/10.1212\/WNL.0000000000002923","journal-title":"Neurology"},{"key":"1516_CR49","doi-asserted-by":"publisher","unstructured":"Gaillard, F., Smith, D. Entorhinal cortical atrophy score. Reference article, Radiopaedia.org. (accessed on 07 Apr 2022) https:\/\/doi.org\/10.53347\/rID-89464","DOI":"10.53347\/rID-89464"},{"issue":"3","key":"1516_CR50","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2214\/ajr.149.2.351","volume":"8","author":"F Fazekas","year":"1987","unstructured":"Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA (1987) MR signal abnormalities at 1 5 T in Alzheimer\u2019s dementia and normal aging. Am J Neuroradiol 8(3):421\u2013426. https:\/\/doi.org\/10.2214\/ajr.149.2.351","journal-title":"Am J Neuroradiol"},{"issue":"9","key":"1516_CR51","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1161\/str.0b013e3182299496","volume":"42","author":"PB Gorelick","year":"2011","unstructured":"Gorelick PB, Scuteri A, Black SE (2011) American Heart Association Stroke Council Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 42(9):2672\u20132713. https:\/\/doi.org\/10.1161\/str.0b013e3182299496","journal-title":"Stroke"},{"key":"1516_CR52","doi-asserted-by":"publisher","unstructured":"Hachinski, V. (Ed.). (2018).\u00a0Treatable and potentially preventable dementias. Cambridge University Press. https:\/\/doi.org\/10.1017\/9781316662007","DOI":"10.1017\/9781316662007"},{"issue":"1","key":"1516_CR53","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, de Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen M-R, Wiklund O (2020) 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Eur Heart J 41(1):111\u2013188. https:\/\/doi.org\/10.1093\/eurheartj\/ehz455","journal-title":"Eur Heart J"},{"issue":"36","key":"1516_CR54","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, Burri H, Butler J, \u010celutkien\u0117 J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Kathrine Skibelund A (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599\u20133726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"issue":"4","key":"1516_CR55","doi-asserted-by":"publisher","first-page":"437","DOI":"10.31887\/dcns.2016.18.4\/cepperson","volume":"18","author":"JL Podcasy","year":"2016","unstructured":"Podcasy JL, Epperson CN (2016) Considering sex and gender in Alzheimer disease and other dementias. Dialog Clin Neurosci 18(4):437. https:\/\/doi.org\/10.31887\/dcns.2016.18.4\/cepperson","journal-title":"Dialog Clin Neurosci"},{"issue":"9","key":"1516_CR56","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.jalz.2018.04.008","volume":"14","author":"RA Nebel","year":"2018","unstructured":"Nebel RA, Aggarwal NT, Barnes LL, Gallagher A, Goldstein JM, Kantarci K, Mielke MM (2018) Understanding the impact of sex and gender in Alzheimer\u2019s disease: a call to action. Alzheimers Dement 14(9):1171\u20131183. https:\/\/doi.org\/10.1016\/j.jalz.2018.04.008","journal-title":"Alzheimers Dement"},{"issue":"12","key":"1516_CR57","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s40265-021-01569-z","volume":"81","author":"S Dhillon","year":"2021","unstructured":"Dhillon S (2021) Aducanumab: first approval. Drugs 81(12):1437\u20131443. https:\/\/doi.org\/10.1007\/s40265-021-01569-z","journal-title":"Drugs"},{"key":"1516_CR58","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/alz.12638","volume":"18","author":"Alzheimer\u2019s Association,","year":"2022","unstructured":"Alzheimer\u2019s Association, (2022) 2022 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement 18:700\u2013789. https:\/\/doi.org\/10.1002\/alz.12638","journal-title":"Alzheimer's Dement"},{"issue":"2","key":"1516_CR59","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/13546805.2019.1700105","volume":"25","author":"H-G Kim","year":"2020","unstructured":"Kim H-G, Jung H-S, Koo B-H, Cheon E-J (2020) Neuropsychological predictors of cognitive deterioration in non-demented individuals. Cogn Neuropsych 25(2):99\u2013112. https:\/\/doi.org\/10.1080\/13546805.2019.1700105","journal-title":"Cogn Neuropsych"},{"issue":"2","key":"1516_CR60","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00415-018-9164-5","volume":"266","author":"S Mazzeo","year":"2019","unstructured":"Mazzeo S, Padiglioni S, Bagnoli S, Bracco L, Nacmias B, Sorbi S, Bessi V (2019) The dual role of cognitive reserve in subjective cognitive decline and mild cognitive impairment: A 7-year follow-up study. J Neurol 266(2):487\u2013497. https:\/\/doi.org\/10.1007\/s00415-018-9164-5","journal-title":"J Neurol"},{"issue":"1","key":"1516_CR61","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/hbm.25216","volume":"42","author":"L Yue","year":"2021","unstructured":"Yue L, Hu D, Zhang H, Wen J, Wu Y, Li W, Sun L, Li X, Wang J, Li G, Wang T, Shen D, Xiao S (2021) Prediction of 7-year\u2019s conversion from subjective cognitive decline to mild cognitive impairment. Hum Brain Mapp 42(1):192\u2013203. https:\/\/doi.org\/10.1002\/hbm.25216","journal-title":"Hum Brain Mapp"},{"issue":"1","key":"1516_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-017-0240-3","volume":"9","author":"SJ Andrews","year":"2017","unstructured":"Andrews SJ, Eramudugolla R, Velez JI, Cherbuin N, Easteal S, Anstey KJ (2017) Validating the role of the Australian National University Alzheimer\u2019s Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a population-based cohort of older adults followed for 12 years. Alzheimer\u2019s Res Ther 9(1):1\u201312. https:\/\/doi.org\/10.1186\/s13195-017-0240-3","journal-title":"Alzheimer's Res Ther"},{"issue":"4","key":"1516_CR63","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.3390\/jcm9041076","volume":"9","author":"O Katayama","year":"2020","unstructured":"Katayama O, Lee S, Bae S, Makino K, Shinkai Y, Chiba I, Harada K, Shimada H (2020) Modifiable risk factor possession patterns of dementia in elderly with mci: a 4\u00a0year repeated measures study. J Clin Med 9(4):1076. https:\/\/doi.org\/10.3390\/jcm9041076","journal-title":"J Clin Med"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-022-01516-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00406-022-01516-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-022-01516-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T03:15:56Z","timestamp":1685675756000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00406-022-01516-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,21]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["1516"],"URL":"https:\/\/doi.org\/10.1007\/s00406-022-01516-3","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,21]]},"assertion":[{"value":"27 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have not conflicts of interest to disclose in relation to the present article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}